Physician profile
Raymond Lesser
NPI 1871538900
$5,508.07
in general payments reported to CMS, 2019-2025
18 companies · $850 in 2025
The $850 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $285 · 2021: $945 · 2022: $779 · 2023: $1,085 · 2024: $720 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,637 · Education: $17.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,636.82 |
| Education | $17.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $2,030.90 | 2019-2025 | |
| Genzyme Corporation | $748.91 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $656.94 | 2020-2025 | Dupixent |
| Stryker Corporation | $573.42 | 2019-2025 | Scopis Ent, Xpress Ent Dilation System |
| Glaxosmithkline, LLC. | $398.66 | 2021-2025 | Nucala |
| Intersect Ent, INC. | $224.38 | 2019-2022 | |
| Integra Lifesciences Corporation | $219.72 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Acclarent, INC | $160.44 | 2019-2023 | Trudi Nav Cable |
| Alk-Abello, INC | $145.72 | 2019-2023 | Timothy, Standardized, Alternaria Tenuis, Histamine Positive |
| Phathom Pharmaceuticals, INC. | $124.74 | 2024 | Voquezna |
| Inspire Medical Systems, INC. | $55.72 | 2023 | Inspire |
| Aerin Medical INC. | $44.94 | 2025 | |
| Depuy Synthes Sales INC. | $25.46 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.18 | 2019 | |
| Merck Sharp & Dohme LLC | $20.38 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $19.61 | 2025 | Xhance |
| Cochlear Americas | $17.69 | 2019 | |
| Karl Storz Endoscopy-America | $17.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Lesser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.